Form 4 for HCA HCA Healthcare
Accepted 2024-02-06 00:00:00 ET · period of report 2024-02-02 · accession 0001209191-24-002936 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-06 | 2024-02-02+ | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | M - OptEx | $231.79 | +6,435 | 8,937 | +257% | +$1.49M |
| DM | 2024-02-06 | 2024-02-02+ | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | F - Tax | $309.42 | -5,161 | 9,188 | -36% | -$1.60M |
| D | 2024-02-06 | 2024-02-05 | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | S - Sale+OE | $312.00 | -1,645 | 7,646 | -18% | -$513.2K |
| DM | 2024-02-06 | 2024-02-02+ | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | M - OptEx | $0.00 | -6,435 | 920 | -87% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-02 | M | A | 2,775 | $236.61 | 13,052 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-02 | M | A | 1,263 | $253.30 | 14,315 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-03 | M | A | 137 | — | 9,325 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2024-02-03 | F | D | 34 | $309.42 | 9,291 | D | — | — | |
| 5 | Common | Common Stock | 2024-02-05 | S | D | 1,645 | $312.00 | 7,646 | D | — | — | |
| 6 | Common | Common Stock | 2024-02-02 | M | A | 1,340 | $241.81 | 10,277 | D | — | — | |
| 7 | Common | Common Stock | 2024-02-02 | M | A | 920 | $173.12 | 8,937 | D | — | — | |
| 8 | Common | Common Stock | 2024-02-02 | F | D | 5,127 | $309.42 | 9,188 | D | — | — | |
| 9 | Derivative | Restricted Stock Units | 2024-02-03 | M | D | 137 | $0.00 | 138 | D | — · — to 2031-02-03 | 137 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F6) The restricted stock units vest in four equal annual installments beginning February 3, 2022. |
| 10 | Derivative | Stock Appreciation Right | 2024-02-02 | M | D | 1,263 | $0.00 | 3,789 | D | $253.30 · — to 2033-01-30 | 1,263 Common Stock | (F5) The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. |
| 11 | Derivative | Stock Appreciation Right | 2024-02-02 | M | D | 2,775 | $0.00 | 2,775 | D | $236.61 · — to 2032-01-28 | 2,775 Common Stock | (F4) The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023. |
| 12 | Derivative | Stock Appreciation Right | 2024-02-02 | M | D | 1,340 | $0.00 | 1,340 | D | $241.81 · — to 2031-10-25 | 1,340 Common Stock | (F3) The stock appreciation rights vest in four equal annual installments beginning on October 25, 2022. |
| 13 | Derivative | Stock Appreciation Right | 2024-02-02 | M | D | 920 | $0.00 | 920 | D | $173.12 · — to 2031-02-03 | 920 Common Stock | (F2) The stock appreciation rights vest in four equal annual installments beginning on February 3, 2022. |